Name | ethyl 2-(6-oxo-1H-pyrimidin-5-yl)acetate |
---|---|
Synonyms |
4-Hydroxy-5-ethoxycarbonylmethyl-pyrimidin
4-Hydroxy-pyrimidyl-5-essigsaeure-ethylester 2-(6-oxo-1H-pyrimidin-5-yl)acetic acid ethyl ester |
Density | 1.268g/cm3 |
---|---|
Boiling Point | 314.46ºC at 760 mmHg |
Molecular Formula | C8H10N2O3 |
Molecular Weight | 182.17700 |
Flash Point | 143.981ºC |
Exact Mass | 182.06900 |
PSA | 72.31000 |
LogP | 0.28780 |
Index of Refraction | 1.538 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933599090 |
~39% 6214-46-6 |
Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; Location in patent: Page/Page column 133 ; |
~% 6214-46-6 |
Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
~% 6214-46-6 |
Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
Precursor 3 | |
---|---|
DownStream 1 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |